— Know what they know.
Not Investment Advice
Also trades as: SMSPHARMA.NS (NSE) · $vol 3M

SMSPHARMA.BO BSE

SMS Pharmaceuticals Limited
1W: -0.6% 1M: +27.7% 3M: +11.1% YTD: +47.9% 1Y: +103.6% 3Y: +294.9% 5Y: +157.1%
₹477.65 ($4.96)
+7.90 (+1.68%)
 
BSE · Healthcare · Drug Manufacturers - General · Tech Score Strong Buy · Power 72 · ₹44.1B mcap · 5M float · 0.573% daily turnover
Smart Money Score
No convergence signal
Key Statistics
Market Cap₹44.1B ($457.7M)
52W Range252.95-494.4
Volume23,949
Avg Volume26,488
Beta1.15
Dividend₹0.40
Analyst Ratings
No analyst coverage
Company Info
CEORamesh Babu Potluri
Employees1,617
SectorHealthcare
IndustryDrug Manufacturers - General
IPO Date2007-02-28
Trendset Jayabheri Connect
Hyderabad, TS 500084
IN
91 40 2525 9999
About SMS Pharmaceuticals Limited

SMS Pharmaceuticals Limited, an India-based entity, specializes in the production and commercialization of active pharmaceutical ingredients (APIs) and related intermediates. The company's extensive product portfolio addresses various therapeutic areas, such as anti-ulcer, anti-fungal, anti-migraine, anti-diabetic, anti-epileptic, anti-psychotic, anti-inflammatory, anti-viral, anti-coagulant, and anti-retroviral treatments. In addition to its manufacturing activities, the firm engages in contract research. Established in 1987 and headquartered in Hyderabad, India, SMS Pharmaceuticals Limited not only supplies the domestic market but also ships its products globally.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms